Publication Name	World Journal of Transplantation
Manuscript ID	40339
Country	Norway

Received	2018-06-23 10:02
Peer-Review Started	2018-06-24 06:15
To Make the First Decision	2018-07-19 07:47
Return for Revision	2018-07-23 06:52
Revised	2018-07-29 19:59
Second Decision	2018-08-06 10:01
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2018-08-06 21:43
Articles in Press	2018-08-06 21:43
Publication Fee Transferred
Edit the Manuscript by Language Editor	2018-08-18 21:20
Typeset the Manuscript	2018-09-06 04:10
Publish the Manuscript Online	2018-09-07 06:15

ISSN	2220-3230 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Randomized Clinical Trial
Article Title	Clinical features and determinants of VO2peak in de novo heart transplant recipients
Manuscript Source	Unsolicited Manuscript
All Author List	Katrine Rolid, Arne K Andreassen, Marianne Yardley, Elisabeth Bjørkelund, Kristjan Karason, Julia P Wigh, Christian H Dall, Finn Gustafsson, Lars Gullestad and Kari Nytrøen
ORCID	Author(s) ORCID Number Katrine Rolid http://orcid.org/0000-0003-0670-9312 Arne K Andreassen http://orcid.org/0000-0001-6588-1273 Marianne Yardley http://orcid.org/0000-0002-6411-6665 Elisabeth Bjørkelund http://orcid.org/0000-0002-1598-2751 Kristjan Karason http://orcid.org/0000-0002-2802-1191 Julia P Wigh http://orcid.org/0000-0002-0399-6902 Christian H Dall http://orcid.org/0000-0002-5075-0980 Finn Gustafsson http://orcid.org/0000-0003-2144-341X Lars Gullestad http://orcid.org/0000-0002-5932-6641 Kari Nytrøen http://orcid.org/0000-0002-4827-4700
Funding Agency and Grant Number	Funding Agency Grant Number the Norwegian Health Association 12906 the South-Eastern Norway Regional Authority 2013111 Scandiatransplant
Corresponding Author	Katrine Rolid, BSc, MSc, Physiotherapist, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Postbox 4950 Nydalen, Oslo 0424, Norway. katrine.rolid@medisin.uio.no
Key Words	Cardiopulmonary exercise testing; Early VO2peak; De novo heart transplant; Health related quality of life; Muscle strength
Core Tip	This de novo heart transplant (HTx) cohort de­monstrated a median peak oxygen consumption (VO2peak) level of 19.4 mL/kg per min at 11 ± 1.8 wk post-HTx, which is comparable to what is shown in maintenance HTx recipients. VO2peak in this study was determined by both central and peripheral factors. The strongest predictors were O2 pulse, heart rate reserve and muscular exercise capacity. Maximal exercise testing provides valuable information for clinical use and future prognosis and can be safely performed as early as 11 wk post-HTx.
Publish Date	2018-09-07 06:15
Citation	Rolid K, Andreassen AK, Yardley M, Bjørkelund E, Karason K, Wigh JP, Dall CH, Gustafsson F, Gullestad L, Nytrøen K. Clinical features and determinants of VO2peak in de novo heart transplant recipients. World J Transplant 2018; 8(5): 188-197
URL	http://www.wjgnet.com/2220-3230/full/v8/i5/188.htm
DOI	http://dx.doi.org/10.5500/wjt.v8.i5.188

Full Article (PDF)	WJT-8-188.pdf
CONSORT 2010 Statement	40339-CONSORT 2010 statement.pdf
Manuscript File	40339-Review.docx
Answering Reviewers	40339-Answering reviewers.pdf
Audio Core Tip	40339-Audio core tip.mp3
Biostatistics Review Certificate	40339-Biostatistics statement.pdf
Clinical Trial Registration Statement	40339-Clinical trial registration statement.pdf
Conflict-of-Interest Disclosure Form	40339-Conflict-of-interest statement.pdf
Copyright License Agreement	40339-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	40339-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s)	40339-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	40339-Institutional review board statement.pdf
Supplementary Material	40339-Supplementary-Material-revision.docx
Peer-review Report	40339-Peer-review(s).pdf
Scientific Misconduct Check	40339-Scientific misconduct check.pdf
Scientific Editor Work List	40339-Scientific editor work list.pdf